ROS Acts as a Double-Edged Sword in the Pathogenesis of Type 2 Diabetes Mellitus: Is Nrf2 a Potential Target for the Treatment?

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|11|12|1082-1092

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.11, Iss.12, 2011-10, pp. : 1082-1092

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

SHIP2: An Emerging Target for the Treatment of Type 2 Diabetes Mellitus

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 3, Iss. 4, 2003-12 ,pp. : 291-298

Bentham Science Publishers

Access to resources Recommend Favorite

The Hot and Potential Targets of Type 2 Diabetes Mellitus Treatment in Recent Decade

By  

Current Drug Targets, Vol. 19, Iss. 1, 2018-01 ,pp. : 55-69

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of Sexually Transmitted Infections with Single-Dose Therapy: A Double-Edged Sword

By Kingston M.   Carlin E.  

Drugs, Vol. 62, Iss. 6, 2002-01 ,pp. : 871-878

Adis International

Access to resources Recommend Favorite

Orlistat: In the Prevention and Treatment of Type 2 Diabetes Mellitus

By Keating G.M.   Jarvis B.  

Drugs, Vol. 61, Iss. 14, 2001-01 ,pp. : 2107-2119

Adis International

Access to resources Recommend Favorite

Meglitinide Analogues in the Treatment of Type 2 Diabetes Mellitus

By Landgraf R.  

Drugs & Aging, Vol. 17, Iss. 5, 2000-11 ,pp. : 411-425

Adis International

Access to resources Recommend Favorite